Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Financial Flexibility Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥24.82 Million (operating CF CN¥15.57 Million minus capex CN¥9.26 Million) represents 0% of total liabilities (CN¥373.70 Million). Also explore Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A across 15 annual periods. Check asset allocation strategy of Wuhan Easy Diagnosis Biomedicine Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
Year-by-year free cash flow to debt coverage for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A. For the full company profile including market capitalisation, see market cap of Wuhan Easy Diagnosis Biomedicine Co Ltd .
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥20.84 Million | CN¥-70.05 Million | CN¥324.56 Million | ▼ -63.0% |
| 2024 | 0.17x | CN¥99.72 Million | CN¥-85.05 Million | CN¥574.40 Million | ▼ -62.2% |
| 2023 | 0.46x | CN¥502.47 Million | CN¥392.50 Million | CN¥1.09 Billion | ▼ -74.3% |
| 2022 | 1.79x | CN¥4.33 Billion | CN¥4.01 Billion | CN¥2.42 Billion | ▼ -17.6% |
| 2021 | 2.17x | CN¥1.23 Billion | CN¥1.13 Billion | CN¥567.02 Million | ▲ +74.4% |
| 2020 | 1.24x | CN¥387.97 Million | CN¥359.68 Million | CN¥311.77 Million | ▼ -47.9% |
| 2019 | 2.39x | CN¥54.42 Million | CN¥22.49 Million | CN¥22.80 Million | ▼ -42.1% |
| 2018 | 4.12x | CN¥101.15 Million | CN¥53.67 Million | CN¥24.55 Million | ▼ -39.1% |
| 2017 | 6.76x | CN¥92.01 Million | CN¥46.50 Million | CN¥13.60 Million | ▲ +50.6% |
| 2016 | 4.49x | CN¥99.13 Million | CN¥58.86 Million | CN¥22.07 Million | ▲ +80.5% |
| 2015 | 2.49x | CN¥46.20 Million | CN¥45.02 Million | CN¥18.57 Million | ▲ +37.2% |
| 2014 | 1.81x | CN¥20.71 Million | CN¥16.47 Million | CN¥11.42 Million | ▲ +104.7% |
| 2013 | 0.89x | CN¥9.03 Million | CN¥6.30 Million | CN¥10.19 Million | ▲ +77.3% |
| 2012 | 0.50x | CN¥1.62 Million | CN¥1.03 Million | CN¥3.23 Million | ▲ +369.2% |
| 2011 | -0.19x | CN¥-359.32K | CN¥-482.90K | CN¥1.94 Million | — |